An initiative in Zambia is showing that a profit-seeking company can help rural farmers battling extreme weather breed chickens that lay more eggs.
Category: Foreign Aid
-
Russell Vought, Trump’s Budget Chief, Wants to Cut ‘Woke’ Spending
Russell T. Vought, leader of the Office of Management and Budget, aims to marry extreme austerity with his Christian values.
-
Trump Leads a ‘Machinery’ of Misinformation in Second Term
President Trump’s first four years in the White House were filled with falsehoods. Now he and those around him are using false claims to justify their policy changes.
-
What 6 Americans Thought of Trump’s Speech
For many reluctant Trump voters, there was a mixture of confidence, anxiety, hope and frustration — along with some anger directed at Congressional Democrats.
-
Trump Celebrates Disruption in Speech to Congress, and Avoids the Costs
The president’s speech to Congress covered tariffs, Ukraine and cuts to the federal work force but did little to address the perils that accompany the abrupt shifts he has engineered.
-
Cuts at USAID and Elsewhere Strains Global Journalism
Investigative journalists around the world relied on funding from the U.S. Now, those watchdogs are scrambling to survive a sudden cash crunch.
-
Benjamin Black Weighs Shift in U.S.A.I.D. Funding
Benjamin Black, a son of the private equity mogul Leon Black and likely head of the International Development Finance Corporation, wants a piece of U.S.A.I.D.’s funding to invest in “pro-market” projects overseas.
-
Trump’s Funding Freezes Bruise a Core Constituency: Farmers
A rapid-fire array of directives by the Trump administration have left farmers and businesses in rural America reeling.
-
How U.S.A.I.D. Affects National Parks and Conservation Worldwide
Among the programs affected by the possible freeze of American foreign aid are those that establish and support overseas national parks and conservation areas.
-
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
